DermTech, Inc. (DMTK)
NASDAQ: DMTK · IEX Real-Time Price · USD
3.50
-0.20 (-5.41%)
At close:
Mar 17, 2023, 4:00 PM
3.40
-0.10 (-2.86%)
After-hours:
Mar 17, 2023, 7:30 PM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2016 |
|---|---|---|---|---|---|---|
| Revenue | 14.52 | 11.84 | 5.89 | 3.36 | 2.44 | 0 |
| Revenue Growth (YoY) | 22.64% | 101.16% | 74.94% | 37.76% | - | - |
| Cost of Revenue | 13.87 | 10.56 | 5.98 | 3.3 | 2.63 | 0 |
| Gross Profit | 0.65 | 1.27 | -0.1 | 0.06 | -0.19 | 0 |
| Selling, General & Admin | 94.76 | 62.41 | 29.9 | 15.17 | 6.32 | 0 |
| Research & Development | 24.05 | 16.26 | 5.29 | 2.5 | 2.05 | 0 |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 118.81 | 78.67 | 35.19 | 17.67 | 8.38 | 0 |
| Operating Income | -118.17 | -77.4 | -35.29 | -17.61 | -8.56 | -0 |
| Interest Expense / Income | 0 | 0 | 0 | 0 | 1.09 | 0 |
| Other Expense / Income | -1.48 | 0.94 | 1.19 | 2.53 | 0.35 | - |
| Pretax Income | -116.68 | -78.34 | -36.48 | -20.13 | -10 | -0 |
| Net Income | -116.68 | -78.34 | -36.48 | -20.13 | -10 | -0 |
| Shares Outstanding (Basic) | 30 | 29 | 17 | 7 | 4 | 2 |
| Shares Outstanding (Diluted) | 30 | 29 | 17 | 7 | 4 | 2 |
| Shares Change | 4.00% | 70.12% | 142.39% | 58.81% | 135.25% | - |
| EPS (Basic) | -3.88 | -2.71 | -2.15 | -2.87 | -2.27 | - |
| EPS (Diluted) | -3.88 | -2.71 | -2.15 | -2.87 | -2.27 | - |
| Free Cash Flow Per Share | -3.28 | -2.24 | -1.80 | -2.57 | -1.73 | 0.00 |
| Gross Margin | 4.46% | 10.76% | -1.63% | 1.78% | -7.58% | - |
| Operating Margin | -813.92% | -653.81% | -599.64% | -523.34% | -350.53% | - |
| Profit Margin | -803.71% | -661.72% | -619.83% | -598.39% | -409.66% | - |
| Free Cash Flow Margin | -678.92% | -547.61% | -518.57% | -535.11% | -311.92% | - |
| EBITDA | -112.22 | -76.04 | -35.99 | -20.04 | -8.84 | -0 |
| EBITDA Margin | -772.99% | -642.33% | -611.57% | -595.75% | -361.79% | - |
| Depreciation & Amortization | 4.46 | 2.3 | 0.49 | 0.09 | 0.08 | 0 |
| EBIT | -116.68 | -78.34 | -36.48 | -20.13 | -8.91 | -0 |
| EBIT Margin | -803.71% | -661.72% | -619.83% | -598.39% | -364.91% | - |
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).